PGNX

Progenics Pharmaceuticals Inc
PGNX

Delisted

PGNX was delisted on the 19th of June, 2020.

152 hedge funds and large institutions have $478M invested in Progenics Pharmaceuticals Inc in 2018 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 63 increasing their positions, 37 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
152
Holders Change
-1
Holders Change %
-0.65%
% of All Funds
3.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
63
Reduced
37
Closed
21
Calls
$12M
Puts
$10.6M
Net Calls
+$1.46M
Net Calls Change
+$2.45M
Name Holding Trade Value Shares
Change
Shares
Change %
GCP
151
GSA Capital Partners
United Kingdom
-$336K -56,543 Closed
Tudor Investment Corp
152
Tudor Investment Corp
Connecticut
-$189K -31,817 Closed
Los Angeles Capital Management
153
Los Angeles Capital Management
California
-$171K -28,770 Closed
CSS
154
Cubist Systematic Strategies
Connecticut
-$159K -26,747 Closed
Wolverine Trading
155
Wolverine Trading
Illinois
-$126K -21,114 Closed
N
156
Natixis
France
-$112K -17,463 Closed
JT
157
Jump Trading
Illinois
-$99K -16,686 Closed
AG
158
Aperio Group
California
-$99K -16,653 Closed
DWM
159
Dorchester Wealth Management
Quebec, Canada
-$89K -15,000 Closed
SC
160
Searle & Co
Connecticut
-$86K -14,500 Closed
SCM
161
Stevens Capital Management
Pennsylvania
-$85K -14,271 Closed
Walleye Trading
162
Walleye Trading
New York
-$50 -8,448 Closed
PAM
163
Panagora Asset Management
Massachusetts
-$21K -3,581 Closed
PHK
164
Point72 Hong Kong
Hong Kong
-$19K -3,267 Closed
Pacer Advisors
165
Pacer Advisors
Pennsylvania
-$14K -2,400 Closed
KF
166
Krilogy Financial
Missouri
-$2K -300 Closed
AssetMark Inc
167
AssetMark Inc
California
-$1K -222 Closed
MA
168
MUFG Americas
New York
-$1K -134 Closed